Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation

International Journal of Neuropsychopharmacology

Volumn 10, Issue 3, 2007, Pages 309-320

  Gutknecht, Lise ^a   Jacob, Christian ^a   Strobel, Alexander ^b   Kriegebaum, Claudia ^a   Müller, Johannes ^b   Zeng, Yong ^a   Markert, Christoph ^a   Escher, Andrea ^a   Wendland, Jens ^a   Reif, Andreas ^a   Mössner, Rainald ^a   Gross, Cornelius ^c   Brocke, Burkhard ^b   Lesch, Klaus Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

Anxiety; Emotion regulation; Gene variation; Personality disorders; Personality traits; Serotonin; Tryptophan hydroxylase 2

Indexed keywords

SEROTONIN; TRYPTOPHAN HYDROXYLASE 2;

ADULT; ALLELE; AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EMOTIONAL DISORDER; EMOTIONALITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HARM REDUCTION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PERSONALITY; PERSONALITY DISORDER; PERSONALITY TEST; PRIORITY JOURNAL; QUESTIONNAIRE; SEROTONIN METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED INTERVIEW; TRANSCRIPTION REGULATION;

ADOLESCENT; ADULT; AFFECTIVE SYMPTOMS; ANXIETY; BRAIN CHEMISTRY; COHORT STUDIES; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PERSONALITY; PERSONALITY DISORDERS; PERSONALITY TESTS; PSYCHIATRIC STATUS RATING SCALES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE; VARIATION (GENETICS);

EID: 34247857430     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706007437     Document Type: Article

References (51)

1. Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, Maier SF (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature Neuroscience 8, 365-371.
2. Bach-Mizrachi H, Underwood MD, Kassir SA, Bakalian MJ, Sibille E, Tamir H, Mann JJ, Arango V (2005). Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 31, 814-824.
3. Blakely RD (2005). Overview: a rare opportunity or just one less reason to be depressed. Neuron 48, 701-702; author reply, 705-706.
4. Brown SM, Peet E, Manuck SB, Williamson DE, Dahl RE, Ferrell RE, Hariri AR (2005). A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Molecular Psychiatry 10, 884-888.
5. Canli T, Congdon E, Gutknecht L, Constable RT, Lesch KP (2005). Amygdala responsiveness is modulated by tryptophan hydroxylase-2 gene variation. Journal of Neural Transmission 112, 1479-1485.
6. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC (2004). Cognitive inflexibility after prefrontal serotonin depletion. Science 304, 878-880.
7. Cloninger CR (1987). A systematic method for clinical description and classification of personality variants. A proposal. Archives of General Psychiatry 44, 573-588.
8. Cloninger CR, Przybeck TR, Svrakic DM (1991). The Tridimensional Personality Questionnaire: U.S. normative data. Psychology Report 69, 1047-1057.
9. Cools R, Calder AJ, Lawrence AD, Clark L, Bullmore E, Robbins TW (2005). Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces. Psychopharmacology (Berlin) 180, 670-679.
10. Costa Jr. P, McCrae RR (1992). Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI). Psychological Assessment Resources. Odessa, FL.
11. De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH (2005). Tryptophan hydroxylase 2 gene expression and promoter polymorphisms in bipolar disorder and schizophrenia. Psychopharmacology (Berlin) 183, 378-382.
12. De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH (2006). Gene expression of tryptophan hydroxylase 2 in post-mortem brain of suicide subjects. International Journal of Neuropsychopharmacology 9, 21-25.
13. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nothen MM, Maffei P, Franke P, Fritze J, et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Human Molecular Genetics 8, 621-624.
14. Evers EA, Cools R, Clark L, van der Veen FM, Jolles J, Sahakian BJ, Robbins TW (2005). Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology 30, 1138-1147.
15. Hariri AR, Drabant EM, Munoz KE, Kolachana BS, Mattay VS, Egan MF, Weinberger DR (2005). A susceptibility gene for affective disorders and the response of the human amygdala. Archives of General Psychiatry 62, 146-152.
16. Harvey M, Shink E, Tremblay M, Gagne B, Raymond C, Labbe M, Walther DJ, Bader M, Barden N (2004). Support for the involvement of TPH2 gene in affective disorders. Molecular Psychiatry 9, 980-981.
17. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D, Klein S, Grusser SM, Flor H, Schumann G, et al. (2005). Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nature Neuroscience 8, 20-21.
18. Heinzel A, Bermpohl F, Niese R, Pfennig A, Pascual-Leone A, Schlaug G, Northoff G (2005). How do we modulate our emotions? Parametric fMRI reveals cortical midline structures as regions specifically involved in the processing of emotional valences. Brain Research. Cognitive Brain Research 25, 348-358.
19. Herrmann MJ, Huter T, Muller F, Muhlberger A, Pauli P, Reif A, Renner T, Canli T, Fallgatter AJ, Lesch KP (2006). Additive effects of serotonin transporter and tryptophan hydroxylase-2 gene variation on emotional processing. Cerebral Cortex. Published online: 26 June 2006. PMID: 16801378.
20. Jacob CP, Muller J, Schmidt M, Hohenberger K, Gutknecht L, Reif A, Schmidtke A, Mossner R, Lesch KP (2005). Cluster B personality disorders are associated with allelic variation of monoamine oxidase A activity. Neuropsychopharmacology 30, 1711-1718.
21. Lander ES, Schork NJ (1994). Genetic dissection of complex traits. Science 265, 2037-2048.
22. Lesch KP (2004). Gene-environment interaction and the genetics of depression. Journal of Psychiatry & Neuroscience 29, 174-184.
23. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
24. Lesch KP, Gutknecht L (2004). Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. International Journal of Neuropsychopharmacology 7, 381-385.
25. Lesch KP, Zeng Y, Reif A, Gutknecht L (2003). Anxiety-related traits in mice with modified genes of the serotonergic pathway. European Journal of Pharmacology 480, 185-204.
26. Loehlin JC (1989). Partitioning environmental and genetic contributions to behavioral development. American Psychologist 44, 1285-1292.
27. Martin-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F (2001). Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. Journal of Neuroscience 21, 9856-9866.
28. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, Hariri A, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, et al. (2006). Neural mechanisms of genetic risk for impulsivity and violence in humans. Proceedings of the National Academy of Sciences USA 103, 6269-6274.
29. 11C]-DASB to the serotonin transporter in baboons: response to acute serotonin deficiency. Biological Psychiatry 57, 102-106.
30. Mossner R, Walitza S, Geller F, Scherag A, Gutknecht L, Jacob C, Bogusch L, Remschmidt H, Simons M, Herpertz-Dahlmann B, et al. (2006). Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. International Journal of Neuropsychopharmacology 9, 437-442.
31. Murphy FC, Smith KA, Cowen PJ, Robbins TW, Sahakian BJ (2002). The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology (Berlin) 163, 42-53.
32. Ostendorf F, Angleitner A (2003). NEO - Persö nlichkeitsinventar (revidierte Form, NEO-PI-R) nach Costa und McCrae. Hogrefe, Hogrefe.
33. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR (2005). 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nature Neuroscience 8, 828-834.
34. Plomin R, Owen MJ, McGuffin P (1994). The genetic basis of complex human behaviors. Science 264, 1733-1739.
35. Preisig M, Ferrero F, Malafosse A (2005). Monoamine oxidase A and tryptophan hydroxylase gene polymorphisms: are they associated with bipolar disorder? American Journal of Pharmacogenomics 5, 45-52.
36. Puig MV, Artigas F, Celada P (2005). Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cerebral Cortex 15, 1-14.
37. Puig MV, Celada P, Diaz-Mataix L, Artigas F (2003). In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cerebral Cortex 13, 870-882.
38. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, et al. (2006). A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Molecular Psychiatry 11, 286-300.
39. Reuter M, Kuepper Y, Hennig J (2006). Association between a polymorphism in the promoter region of the TPH2 gene and the personality trait of harm avoidance. International Journal of Neurpsychopharmacology. doi:10.1017/S1461145706007073.
40. Riedel WJ, Klaassen T, Schmitt JA (2002). Tryptophan, mood, and cognitive function. Brain, Behavior, and Immunity 16, 581-589.
41. Schinka JA, Busch RM, Robichaux-Keene N (2004). A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Molecular Psychiatry 9, 197-202.
42. Sen S, Burmeister M, Ghosh D (2004). Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. American Journal of Medical Genetics. B: Neuropsychiatric Genetics 127, 85-89.
43. Strobel A, Debener S, Anacker K, Muller J, Lesch KP, Brocke B (2004). Dopamine D4 receptor exon III genotype influence on the auditory evoked novelty P3. Neuroreport 15, 2411-2415.
44. Strobel A, Gutknecht L, Zheng Y, Reif A, Brocke B, Lesch KP (2003). Allelic variation of serotonin receptor 1A function is associated with anxiety- and depression-related traits. Journal of Neural Transmission 110, 1445-1453.
45. Walitza S, Renner TJ, Dempfle A, Konrad K, Wewetzer C, Halbach A, Herpertz-Dahlmann B, Remschmidt H, Smidt J, Linder M, et al. (2005). Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Molcular Psychiatry 10, 1126-1132.
46. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M (2003). Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299, 76.
47. Weyers P, Krebs H, Janke W (1995). Reliability and construct validity of a German version of Cloninger's Tridimensional Personality Questionnaire. Personality and Individual Differences 19, 853-861.
48. Yuen EY, Jiang Q, Chen P, Gu Z, Feng J, Yan Z (2005). Serotonin 5-HT1A receptors regulate NMDA receptor channels through a microtubule-dependent mechanism. Journal of Neuroscience 25, 5488-5501.
49. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004). Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305, 217. Zhao JH (2004). 2LD, GENECOUNTING and HAP: computer programs for linkage disequilibrium analysis. Bioinformatics 20, 1325-1326.
50. Zhou Z, Roy A, Lipsky R, Kuchipudi K, Zhu G, Taubman J, Enoch MA, Virkkunen M, Goldman D (2005). Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Archives of General Psychiatry 62, 1109-1118.
51. Zill P, Baghai TC, Zwanzger P, Schule C, Eser D, Rupprecht R, Moller HJ, Bondy B, Ackenheil M (2004). SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Molecular Psychiatry 9, 1030-1036.